Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Baseline characteristics of Study Participants (N =10)

From: A human model of inflammatory cardio-metabolic dysfunction; a double blind placebo-controlled crossover trial

   Mean (SD)
Age (years)   22.7 (3.8)
  Males 20.4 (3.2)
  Females 25.0 (2.9)
BMI (kg/m 2 )   24.0 (2.3)
Waist Circumference (m)   0.85 (0.06)
TNF-α (pg/mL)   0.9 (0.4)
IL-6 (pg/mL)   1.5 (0.8)
CRP (mg/L)   1.2 (1.4)
  Males 0.5 (0.2)
  Females 1.8 (1.7)
Systolic Blood Pressure (mmHg)   115.5 (7.2)
Diastolic Blood Pressure (mmHg)   69.1 (3.3)
Heart rate (bpm)   58.9 (9.9)
Temperature (K)   309.3 (255.4)
Total Cholesterol (mmol/L)   4.42 (0.83)
HDL-C (mmol/L)   1.54 (0.33)
  Males 1.25 (0.09)
  Females 1.83 (0.19)
Triglycerides (mmol/L)   0.89 (0.34)
  Males 0.76 (0.25)
  Females 1.03 (0.39)
LDL-C (mmol/L)   2.22 (0.56)
*FSIGTT-insulin sensitivity index (SI, x 10 -4 (μU/ml) -1 ·min -1 )   3.4 (1.1) ^
HOMA-IR insulin resistance index   10.4 (2.77)
(AIRg, μU·ml -1 ·min)   400.5 (152.6) ^
HOMA-B beta-cell function index   1555.6 (931.3)
  1. *FSIGTT = Frequently Sampled Intravenous Glucose Tolerance Test. † HOMA = Homeostatic Model Assessment ^ In N = 5 subjects.